Devanand Patil

Devanand Patil

Followers 1
Following 50
Life Sciences BPO Market: IntroductionTransparency Market Research has published a new report titled, ‘Global Life Sciences BPO Market’.According to the report, the global life sciences BPO market was valued at ~US$ 214 Bn in 2018 and is projected to expand at a CAGR of ~8% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1782Broad and Growing Product Pipeline to Drive Adoption of Advanced Life Sciences BPORise in demand for new drugs and novel therapies for treatment of diseases such as cancer and immunological disorders coupled with the evolving research & development process has increased the number of compounds in pipeline in the last decade.This in turn drives the global life sciences BPO market.Efforts to Optimize Costs and Development TimeEscalating costs of conducting clinical trials, requirement of data quality, enrollment targets, financial demands regarding setting up of a clinical research practice, and other management related activities drive the outsourcing services.According to the Tufts Center for the Study of Drug Development, outsourcing to CROs has supported companies in keeping R head counts stable, even though the number of active clinical trials across the world has increased by 80%.Moreover, trials outsourced to CROs are, on average, completed 30% sooner than in-house clinical trials, providing an average timesaving of four to five months.Request COVID Analysis on Life Sciences BPO Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1782 Contract Manufacturing Organizations to Lead Global MarketBased on service type, the contract manufacturing organizations segment dominated the global market in 2018.Significant increase in research and development costs, technological developments, and product innovation, which accounts for high R costs prompt several pharmaceutical and medical device companies to outsource preclinical services to CROs.
Ligation Devices Market: IntroductionTransparency Market Research has published a new report titled, ‘Global Ligation Devices Market’.The safety of clips used in ligation is mainly achieved by deep indentation of the metal bar with a high retention force.The minimally invasive surgery segment captured the largest market share in 2019.Ligation Devices Market: Prominent RegionsNorth America held a major share of the global ligation devices market in 2019.Growth of the ligation devices market in the region can be attributed to rise in prevalence of chronic diseases and well-developed healthcare sector in the region.Increase in number of people with cardiovascular diseases, product approvals, and rise in awareness about cardiovascular diseases, which ultimately leads to regular checkup and diagnosis, are factors anticipated to fuel the growth of the ligation devices market in the region.Request COVID Analysis on Ligation Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=61257 Ligation Devices Market: Key PlayersKey players are expanding their footprint to strengthen their positions in the global ligation devices market.Gradual increase in surgical procedures, which includes ligation devices globally offers lucrative opportunities to key players to increase their share in the ligation devices market.
Oncology Nutrition Market: IntroductionTransparency Market Research has published a new report titled, “Global Oncology nutrition Market”.Rise in incidence of malnutrition is also fuelling the growth of the global oncology nutrition market.The development of novel oncology nutrition supplements and rise in R activities for pipeline products are some of the major factors attributed for the growth of global oncology nutrition market.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=46314Elemental Formula to Witness Significant GrowthVarious organizations and governments are making efforts to produce cancer nutrition products to meet the growing demand of malnutrition occur due to cancer due to increase in incidence of cancer.Some of the elemental oncology nutrition products are foreseen to achieve better results for managing malnutrition in the cancer treatment.For instance, an article published by the American Society for Nutrition in 2014 indicated that long-term parenteral nutrition therapy significantly increases the risk of liver disease and metabolic complications in patients.In 2015, private health insurance coverage continued to be more prevalent than public coverage, at 67.2% and 37.1%, respectively.Request Customization on Oncology Nutrition Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=46314 Oncology Nutrition Market: Key PlayersKey players in the global oncology nutrition market focus on strengthening their positions in the global market.
Surgical Masks Market: IntroductionAccording to the report, the global surgical masks market was valued over US$ 15.6 Bn in 2020 and is projected to contract from 2021 to 2030.Surgical masks comprise basic surgical masks, anti-fog surgical masks, fluid/splash resistant surgical masks, N95 masks, and other surgical masks such as high barrier masks.This can be ascribed to rapidly increasing number of COVID-19 cases in the U.S. and government & regulatory policies regarding manufacture as well as import of surgical masks.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=67823Growing Pandemic of COVID-19 to Drive Global MarketCOVID-19, caused by a coronavirus, has been spreading rapidly across the globe.Rise in fear of infection among people and asymptomatic spread of the disease have led to the usage of masks by all people, creating a strong demand for surgical masks.Hence, the growing pandemic of COVID-19, rise in fear among people, and healthcare professionals advocating usage of masks to reduce the risk of infection drive the global surgical masks market.Request COVID Analysis on Surgical Mask Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=67823 Increase in Geriatric Population to Propel Global MarketThe geriatric population i.e., the population aged over 65, has been increasing significantly over the past few years.Aging is associated with declining support for long-term caregiving from families and highly expensive formal long-term caregiving services.
The use of an appropriate facial mask can help remove excess oil, hydrate the skin, improve the appearance of pores on the face, and also help pull out impurities.Appling a facial mask has several other benefits such as it provides relaxation, deep cleaning, unclogs pores, and imparts glowing skin.Read Report Overview-  https://www.transparencymarketresearch.com/facial-mask-market.html The global facial mask market is driven by various factors such as increasing availability of customized products, their ease of use, lifestyle changes, and growing number of beauty shops which are estimated to increase the demand for facial masks during the forecast period.Increasing penetration of new players in the market provides an opportunity to drive the facial mask market during the forecast period.The global facial mask market has been segmented in terms of packaging, mask type, distribution channel, end-user, and region.Based on mask type, the market can be segmented into natural ingredient mask, clay mask, peel off mask, warm oil mask, cream mask, and self or thermal heating mask.Offline distribution channel includes retail store, hyper market, super market, specialty stores, drug and pharmacy stores, direct selling, and others.The end-user segment is further segregated into general consumer use, salon, spa, beauty clinic, and others.Request COVID Analysis on Facial Mask Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=38546  In terms of geography, the facial mask market is divided into North America, Europe, Asia Pacific, Middle East & Africa (MEA), and South America.
Transparency Market Research (TMR) has published a new report titled, ‘Digital Pathology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.According to the report, the global digital pathology market was valued at US$ 0.38 Bn in 2018 and is projected to expand at a CAGR of over 12.0% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1540OverviewDigital pathology (DP) is an image-based platform that involves managing, analyzing and interpreting digital information reflected on a digitized slide.Digital pathology is poised to streamline the workflow and activities of diagnostic laboratories and pathologists in near futureDigital pathology market is currently booming owing to rise in research and development activities.Surge in incidence and prevalence of chronic diseases and demand for advanced therapeutics are leading to increase in demand for new drugs and medicines.This in turn is increase in focus of research and development.Increase in number of trade fairs and exhibitions are creating awareness about the benefits of digital pathology solution.Thus, rise in awareness towards usage of digital pathology solutions for diagnosis of disorders and diseases is anticipated to drive the growth of market.North America dominate the global digital pathology market in 2018and the trend is anticipated to continue during the forecast period.
COPD Drug Delivery Devices Market: IntroductionAccording to the report, the global COPD drug delivery devices marketwas valued at ~US$ 8 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027COPD treatment can be carried out using two main devices: inhaler and nebulizerSeveral treatment options are available with inhalers for patients suffering from COPD, including short-acting and long-acting beta2-agonists (SABA/LABA), short-acting and long-acting antimuscarinics (SAMA/LAMA), combination therapy, and triple therapyGrowth of the COPD drug delivery devices market can be attributed to increase in COPD patients across the globeNorth America dominated the global COPD drug delivery devices market in 2018 and the trend is anticipated to continue during the forecast period.Increase in adoption of combination therapy in inhalers, availability of all major companies in the region, and introduction of new drugs in the near future are anticipated to drive the market in North America.Asia Pacific is expected to be a highly lucrative market for COPD drug delivery devices, expanding at a higher CAGR than other regions during the forecast periodRequest Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=74897Rise in Prevalence of COPD and Awareness about COPD Treatment to Drive MarketIncrease in prevalence of COPD across the world is a major cause that can be attributed to the growth of the global COPD drug delivery devices Rise in COPD has been observed due to increase in prevalence of smokers as well as aging population in several countries.The Global Burden of Disease Study reports a prevalence of 251 millioncases of COPD globally in 2016In 2015, 2 millionpeople died from COPD globally, an increase of ~12% compared with 1990.This, in turn, is propelling the COPD drug delivery devicesNovember is considered as the National Chronic Obstructive Pulmonary Disease Awareness Month by the US COPD Coalition to enhance exposure around chronic obstructive pulmonary disease (COPD)Request COVID Analysis on COPD Drug Delivery Devices Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=74897 Use of Inhalers to Increase for COPD Drug DeliveryBased on product, the global COPD drug delivery devices market has been divided into inhaler and nebulizer.Nebulizer is sub-segmented into jet nebulizer, mesh nebulizer, and ultrasonic nebulizer.The inhaler segment dominated the global COPD drug delivery devices market in 2018 and the trend is likely to continue during the forecast period, owing to continuous innovation in long-term therapy such as combination therapy through metered dose inhaler to prevent symptoms.Rise in Adoption of Digital DevicesIn terms of type, the global COPD drug delivery devices market has been bifurcated into manual device and digital deviceThe manual device segment dominated the global COPD drug delivery devices market.However, digital device is expected to grow at a rapid pace during the forecast period.Growth of the digital device segment can be attributed to continuous advancements in the smart technology as well as rise in adoption of digital devices in the healthcare sector for better results Request Customization on COPD Drug Delivery Devices Market Report –  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=74897 Retail Pharmacies a Major Distribution ChannelBased on distribution channel, the global COPD drug delivery devices market has been segmented into retail pharmacies, hospital pharmacies, and online pharmaciesThe retail pharmacies segment dominated the global COPD drug delivery devices market in terms of revenue in 2018 and the trend is projected to continue during the forecast period.Significant growth of the COPD drug delivery devices market in the region can be attributed to high prevalence of COPD and increase in demand for its therapeutics.COPD Drug Delivery Devices Market: Competition LandscapeAstraZeneca plc., Boehringer Ingelheim International GmbH, and GlaxoSmithKline plc are the leading players in the global COPD drug delivery devices market that hold majority of the market shareThe global COPD drug delivery devices market is fragmented in terms of the number of players.
1
Global Swine Respiratory Diseases Treatment Market: SnapshotRespiratory disease in pigs has been a cause of substantial mortality and economic burden or the swine industry.Particularly, according to a statistics, swine respiratory diseases involve multiple infectious agents, and have been one of the key causes of death in nursery pigs.This has invigorated research on the aetiology of pneumonic swine’s lungs—the main agent being mycoplasma hyopneumoniae.Read Report Overview- https://www.transparencymarketresearch.com/swine-respiratory-diseases-treatment-market.html Growing body of research pertaining to metagenomic analysis of murine respiratory tracts has helped in understanding the etiological agents of swine enzootic pneumonia and especially porcine respiratory disease complex.They seem to increasingly focus on infectious diseases, and resultantly expand our understanding of primary respiratory infectious agents—virus as well as bacteria.One of the key pharmaceutical companies Boehringer Ingelheim showing interest in bringing effective control and treatment strategies for PRRSV to the market has sponsored three awards amounting to whopping $35,000.Under the aegis of Awards for Advancing Research in Respiratory Disease, researchers and practicing veterinarians, the company announced, can now apply for any one of the these awards.Such initiatives no doubt promote the spirit of collaborations among researchers, thereby cementing prospects in the global swine respiratory diseases treatment market.The primary pathogens under scanner are porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza virus, and porcine circovirus type 2.
Global Swine Respiratory Diseases Treatment Market: SnapshotRespiratory disease in pigs has been a cause of substantial mortality and economic burden or the swine industry.Particularly, according to a statistics, swine respiratory diseases involve multiple infectious agents, and have been one of the key causes of death in nursery pigs.This has invigorated research on the aetiology of pneumonic swine’s lungs—the main agent being mycoplasma hyopneumoniae.Read Report Overview- https://www.transparencymarketresearch.com/swine-respiratory-diseases-treatment-market.html Growing body of research pertaining to metagenomic analysis of murine respiratory tracts has helped in understanding the etiological agents of swine enzootic pneumonia and especially porcine respiratory disease complex.They seem to increasingly focus on infectious diseases, and resultantly expand our understanding of primary respiratory infectious agents—virus as well as bacteria.One of the key pharmaceutical companies Boehringer Ingelheim showing interest in bringing effective control and treatment strategies for PRRSV to the market has sponsored three awards amounting to whopping $35,000.Under the aegis of Awards for Advancing Research in Respiratory Disease, researchers and practicing veterinarians, the company announced, can now apply for any one of the these awards.Such initiatives no doubt promote the spirit of collaborations among researchers, thereby cementing prospects in the global swine respiratory diseases treatment market.The primary pathogens under scanner are porcine reproductive and respiratory syndrome virus (PRRSV), swine influenza virus, and porcine circovirus type 2.
Therapeutic respiratory devices (TRDs) are meant for therapeutic usage to improve pulmonary function, boost lung oxygenation and aid mucus removal from bronchi during respiratory therapy.TRDs can be of various types such as positive expiratory pressure (PEP) TRDs, oral high frequency oscillation (OHFO) TRDs, intra-pulmonary percussive ventilation (IPV), incentive spirometry (IS) TRDs, high-frequency chest wall oscillation (HFCWO) TRDs, oxygen concentrators (OCs) and others.Other TRDs may include ventilators,nebulizers, inhalers, flutters, acapella, and cornets.In addition, there are several pediatric TRDs which are specifically utilized in facilitating and regulating respiration among infants during post natal care, especially in the case of premature or small for date babies, post-partum complications, etc.Read Report Overview- https://www.transparencymarketresearch.com/therapeutic-respiratory-devices-market.html  The demand for TRDs is on the rise due to high prevalence of respiratory diseases like asthma and chronic obtrusive pulmonary diseases (COPD).Certainly, these features will aid in the development of modern devices that will be preferred over conventional devices that required specialists and large number of hospital visits.The new and advanced TRDs will be highly valued in the therapeutic respiratory devices market as these TRDs are being increasingly utilized during post-operative patient care.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=5660 TRDs can be classified on the basis of their technique and the therapeutic needs.
Respiratory Disorders Treatment Market: IntroductionAccording to the report, the global respiratory disorders treatment market was valued at US$ 65 Bn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027.The anticipated launch of novel therapies in the global respiratory disorders treatment market such as FibroGen’s FG-3019 and Promedior’s PRM-151 for idiopathic pulmonary fibrosis (IPF) are anticipated to augment the global respiratory disorders treatment market.Increase in incorporation of premium priced therapies such as immune checkpoint inhibitor (ICI) immunotherapies into the lung cancer treatment algorithm, particularly in the first-line setting and cystic fibrosis transmembrane conductance regulator (CFTR) modulator in the cystic fibrosis (CF) market is expected to be one major drivers to the market.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=39326 North America dominated the global respiratory disorders treatment market in 2018 and the trend is anticipated to continue during the forecast period.According to the World Health Organization, presently, 235 million people are suffering from asthma across the globe and 338,000 deaths due to asthma were reported in 2015.Request COVID Analysis on Respiratory Disorders Treatment Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=39326 According to the Centers for Disease Control and Prevention (CDC) analysis data, prevalence of asthma was 7.8% in 2015, which increased to 7.9% in 2017 in North America alone.The World Asthma Day is an annual event organized by the Global Initiative for Asthma (GINA) to improve asthma awareness and care around the world.The month of May is considered as National Asthma and Allergy Awareness Month to control asthma and educate people to raise awareness and improve the lives of all people.Combination Drugs to Dominate MarketIn terms of drug class, the global respiratory disorders treatment market has been divided into bronchodilators, corticosteroids, combination drugs, antibiotics, target therapy, immunotherapy, CFTR, and others.
1
This novel technique has been built by scientists of Mars Bioimaging-a manufacturer of small bore spectral CT (Computed Tomography) scanners for pre-clinical medical research at the University of Canterbury, New Zealand, in order to facilitate taking pictures of the internal tissues that interact with bones.This explains why the X-ray market stood at ~US$ 11 Bn in 2019.Read Report Overview- https://www.transparencymarketresearch.com/x-ray-market.html The concept of digital X-ray is engulfing the market landscape.As such, the revenue of mammography is predicted for exponential growth during the forecast period.Cost-efficiency of CT Scanners with Single Chip-photosensor Array and ADC Gain RecognitionThere is a growing demand for low-cost CT medical imaging.For instance, ams AG, formerly known as austriamicrosystems AG-an innovator in advanced sensor solutions, has announced the launch of AS5950, a unique CMOS (Complementary Metal Oxide Semiconductor) device that combines photosensor array with ADC (Analog-to-Digital Converter) to reduce complexity and deploy low-cost CT medical imaging.Companies in the X-ray market are increasing their R activities to fuel the availability of CT scanners that are sustainably more affordable.Hence, companies are integrating photodiodes and ADCs in a single chip to make CT scanners more financially viable.Companies Extend Radiographic Support Solutions amidst COVID-19 CrisisIn support of the global medical community’s ever-evolving COVID-19 (Coronavirus) crisis, companies are increasing their efficacy in radiographic support solutions.They are increasing their focus in dental and forensics communities to generate revenue streams.
Global CAR-T cell therapy Market: OverviewCancer is one of the leading causes of fatalities worldwide.During the time of CAR-T cell therapy, the T-cells of a person are derived, reformed, and the put inside the body of a human being wherein the restructured cells multiply in number and then attack the cancer cells.Read Report Overview- https://www.transparencymarketresearch.com/cart-cell-therapy-market.html Currently, CAR T cell therapy is considered as an extremely effective procedure for the treatment of patients suffering from blood cancer and has already been through other methods of cancer treatment such as chemotherapy.The effectiveness of the process in treating cancer is likely to fuel growth of the global CAR-T cell therapy market in the years to come.Rising incidences of cancer across the globe together with the relentless technological advancement for reliable and effective cancer treatment is expected to favor growth of the global CAR-T cell therapy market over the period of projection, from 2019 to 2027.Furthermore, growing number of clinical studies in cell therapy is estimated boost the market over the period of forecast.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=64910 This report on the global CAR-T cell therapy market offers a closer look at the significant changes that took place in the industry of medical science.The developments are likely to shape the contours of the global CAR-T cell therapy market over the assessment tenure, from 2019 to 2027.The insights offered in the report are estimated to help the industry players and investors to make a correct assessment of the completive ecosystem and make strategies accordingly.Global CAR-T cell therapy Market: Trends and OpportunitiesRising Geriatric Population with Weakening Immune System Boost Market GrowthThe global CAR-T cell therapy market is primarily driven by increasing number of acquisitions, thanks to the augmented importance of cellular therapies.
Global Colposcopy Market: OverviewGrowing incidence of cervical cancer and increasing demand for early diagnostic techniques are the major growth factors driving demand in the global colposcopy market.As per the data reveled by WHO, high number of deaths occur due to cervical cancer in emerging economies.However, this can be managed with early screening programs and diagnostics that will help in detecting these diseases at the earliest.Of these, the hospital segment has created the largest demand for colposcopy due to increasing number of cancer screening initiatives and growing installation of colposcopies in hospitals across the world.This report covers all the major factors contributing in the growth of the global colposcopy market.The information is derived from different sources including interviews, seminars, podcasts, various national and international programmes and sites, and other similar sources.The report is segmented into different sections describing about different categories, vendor landscape, market potential, and geography.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=58560 Global Colposcopy Market: Trends and Opportunities Increasing awareness among females across nations and increasing consciousness related to personal hygiene and regular checkups is projected to stoke up the demand in the global colposcopy market.
Global IoT Medical Devices Market: OverviewThe global IoT market is anticipated to rise at a notable rate owing to the government initiatives in order to promote digital health.Also known as smart healthcare, internet if things in the field of healthcare has turned up to be a boon in terms of connecting medical devices and providing better medical help to people with the help of technology, under the guidance of both human skills and artificial intelligence.Read Report Overview- https://www.transparencymarketresearch.com/iot-medical-devices-market.html There are different variations of the global IoT medical devices market with respect to product, type, connectivity technology, and end-user.Sub-division of implantable cardiac devices are implantable cardiac monitors, pacemakers, and implantable cardioverter defibrillators.Based on categorization by device type, the global IoT medical devices market is divided into wearable medical devices, implantable medical devices, and stationary medical devices.With regard to categorization by end-user, the market is classified into home care centers, long-term care centers, assisted living facilities and nursing homes.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=54573 The report presented above is a complete evaluation of the global IoT medical devices market with large focus on market dynamics.The above presented report also offers geographical as well as other segmentation of the market.Global IoT Medical Devices Market: Trends and OpportunitiesMajor factors to propel the global IoT medical devices market are the growing need for cost efficient services in healthcare and medical sector for patients.The increase in the number of new hospital and medical center set-ups are also creating more opportunities of growth in the years to come.Apart from that patient care and patient engagement is now given more importance which in a way, is adding more boost to  the market as more and more people are opting for IoT medical devices for their family member’s proper hospital care.
Transparency Market Research (TMR) has published a new report titled, ‘Breast Pumps Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.According to the report, the global breast pumps market was valued at US$ 2.3 Bn in 2018 and is projected to expand at a CAGR of 10.4% from 2019 to 2027.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=687OverviewA breast pump is a medical device that is used by lactating women for extracting milk from their breasts if they found it difficult by natural lactation or not sufficient mil is produced by them.These mechanical devices may be manual devices powered by hand or foot movements or automatic devices powered by electricity for end useManual breast pumps are operated by squeezing or pulling a handle in a repetitive fashion, allowing the user to directly control the pressure and frequency of milk expressionNorth America dominated the global breast pumps market in 2018 and the trend is anticipated to continue during the forecast period for both in terms of value and volume.Growing rate of employed women across the globe and government support policies for breastfeeding to Drive MarketSupporting government initiatives aimed at improving consumer awareness levels for breastfeeding is likely to fuel the growth of global breast pumps marketRising employed women ratio across the world and launch of technological advanced products in recent years are also some of the key factors for the growth of global breast pumps marketRising incidences of lactation failure among mothers, improving healthcare infrastructure, and favorable reimbursement policies in developed countries are some of the major factors responsible for the growth of global breast pumps marketFor instance, under the Patient Protection and Affordable Care Act (PPACA), in the U.S. several insurance companies are offering variety of breast pumps for the ease of women’s convenienceRequest COVID Analysis on Breast Pumps Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=687Double Electric Breast Pump Segment to Dominate MarketBased on product type, the global breast pumps market has been divided into single electric breast pump, double electric breast pump, and manual breast pumpIn terms of value double electric breast pump is accounted for major market share in 2018 due to higher cost of product, and growing inclination of consumers toward technologically-advanced productsBased on volume single electric breast pump dominated the global market in 2018 due to ease of use, simple operation, and comparatively lesser time than manual breast pump required for processPersonal Use Application to be Highly Lucrative SegmentIn terms of application, the global breast pumps market has been bifurcated into hospital grade, and personal usePersonal use segment dominated the global breast pump market in 2018 and during the forecast periodPersonal use segment is also more lucrative segment during the forecast period owing to affordable price of products, growing trend of using in home breast pumps among working women, and favorable policies for reimbursementRequest Customization on Breast Pumps Market Report –  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=687North America to Dominate Global MarketIn terms of region, the global breast pumps market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.North America dominated the global breast pumps market in 2018, followed by Europe by both in terms of value as well as volumeNorth America accounted for major share of the global breast pumps market in 2018, owing to higher women employment rate, favorable reimbursement policies, established healthcare infrastructure, and government support policies for working womenFor instance, according to U.S. Department of Labor Blog, there are 6million women in the civilian labor force and around 47% of U.S. workers are women.The breast pumps market in Asia Pacific is anticipated to expand at a higher CAGR from 2019 to 2027.This can be attributed to rising women workforce which demands higher volume of breast pumps in coming years and growing investment made by the government in healthcare sectorBuy Breast Pumps Market Report- https://www.transparencymarketresearch.com/checkout.php?rep_id=687=SCompetitive LandscapeThe global breast pumps market is fragmented in terms of number of players.Key players in the global market include Pigeon Group (Pigeon Corporation), Medela AG, Koninklijke Philips N.V., Ameda, Inc., Ardo Medical Ag, Evenflo Feeding, Inc., Mayborn Group Limited, Spectra Baby USA, Albert Manufacturing USA (Albert Group), and Hygeia Health, among othersThe global Breast Pumps market has been segmented as follows:Global Breast Pumps Market, by Product TypeSingle Electric Breast PumpDouble Electric Breast PumpManual Breast PumpGlobal Breast Pumps Market, by ApplicationHospital GradePersonal UseGlobal Breast Pumps Market, by RegionNorth AmericaS.CanadaEuropeGermanyK.FranceItalySpainRest of EuropeAsia Pacific          ChinaIndiaJapanAustralia & New ZealandRest of Asia PacificLatin AmericaBrazilMexicoRest of Latin AmericaMiddle East & AfricaGCC CountriesSouth AfricaRest of Middle East & AfricaAbout UsTransparency Market Research is a global market intelligence company, providing global business information reports and services.Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research (TMR) has published a new report titled, “Teleradiology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027”.According to the report, the global teleradiology market was valued at US$ 2.6 Bn in 2018 and is projected to expand at a CAGR of 16.9% from 2019 to 2027.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1132OverviewBased on modality, teleradiology market is segmented into X-ray, Ultrasound, CT, MRI, Nuclear ImagingRigorous research and development activities in radiology imaging services and growth in adoption of teleradiology drive the marketNorth America dominated the global teleradiology market in 2018 and the trend is anticipated to continue during the forecast period owing to a highly developed health care sector, coupled with increased awareness among patients, and continuous evolution of information technology.The teleradiology market offers immense growth potential in this region.The teleradiology market in Asia Pacific is anticipated to expand at a significant CAGR during the forecast period due to increase in awareness about teleradiology and growth in the healthcare sector in countries such as China, Japan, and India.Moreover, technological advancement and increasing adoption of teleradiology solutions are expected to propel the growth of the market during the forecast periodRequest COVID Analysis on Teleradiology Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1132 Rise in number of radiology imaging procedures and Public & private players participating to promote teleradiology to Drive Global Teleradiology MarketThe changing face of interventional radiology across the globe and rise in prevalence of chronic diseases such as cancer and coronary heart diseases are boosting the number of radiological procedures.According to the National Cancer Institute, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016The need of time-saving interpretation of radiographs with quality is high in developed economies where incidence rate of chronic diseases is rising at a rapid pace.Key companies are collaborating to improve access to teleradiology in niche markets.
Transparency Market Research (TMR) has published a new report titled, ‘Orthopedic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.Highly structured health care industry, increased usage of technologically advanced surgical procedures, and increasing prevalence of orthopedic diseases are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast periodRequest COVID Analysis on Orthopedic Devices Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1781 Surge in Adoption of Technologically Advanced Products and Increase in Incidence Rates of Injuries Related to Accidents, Sports, and Adventure to Drive MarketLarge number of global manufacturers who have technical expertise and core competencies are undertaking constant efforts to develop and manufacture novel orthopedic products to attract more customers.Improved biomaterial based implants offering high strength and low wear are witnessing an exponential rise in demand in developed as well as developing countriesIncrease in number of accidents and bone disorders such as joint pain, instability in the joint, bone loss, and infection are anticipated to spur demand for orthopedic devices during the forecast period.Over 340,000hip implant procedures are performed in the U.S. each year, which includes a number of patients aged between 40 and 50 who are focused toward maintaining a healthy lifestyleRequest Customization on Orthopedic Devices Market Report –  https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=1781 Joint Reconstruction Segment to Dominate MarketBased on product, the global orthopedic devices market has been divided into joint reconstruction, spinal devices, orthopedic braces and supports, trauma fixation, orthopedic accessories, orthopedic prosthetics, arthroscopy devices and others.Hip replacement is again divided into total hip replacement implant, partial hip replacement implant, hip resurfacing implant, revision hip replacement implant.Significant patient pool leading to increase in surgeries and rise in investment in research and development activities by major players are attributed to the continuous dominance of the joint reconstruction segment.Total knee replacements are one of the most successful procedures in all of medicine.
Foot and Mouth Disease Vaccines Market: IntroductionTransparency Market Research has published a new report titled ‘Global Foot and Mouth Disease Vaccines Market ’.According to the report, the global foot and mouth disease vaccines market was valued at US$ 5.5 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.Foot and mouth disease (FMD) is an acute viral and highly contagious disease, affecting various economically important livestock species.Animals with FMD develop fever and blisters on the lips and tongue in the mouth, on the mammary glands, and around the hooves.The segment is anticipated to expand at a high CAGR during the forecast period, owing to the rise in the need & demand for prevention of the disease across the world.Based on application, the global foot and mouth disease vaccines market has been classified into cattle, sheep & goat, pigs and others (antelope, deer, bison, and camelids).The growth of the foot and mouth disease vaccines market in Asia Pacific can be attributed to rise in acute viral diseases and well-developed animal healthcare sector.
Transparency Market Research (TMR) has published a new report titled, ‘Cord Blood Banking Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.Such preserved cord blood is used in medical therapies in the similar fashion as that of stem cells derived from bone marrow.Cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions.This report studies the current market condition and future potential for the cord blood banking market.North America dominated the global cord blood banking services market in2018 and the trend is anticipated to continue during the forecast period.Adoption of new technologies such as stem cell research, with higher awareness, significant health care spending in overall national budgets, early availability of advanced technologies, and higher penetration of research activities across the country are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast periodRequest COVID Analysis on Cord Blood Banking Services Market –  https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1741High Incidence of genetic disorders and rise in hematopoietic stem cell transplantation rates to Drive MarketHigh incidence of genetic disorders is likely to drive the market.Increasing number of people with cancer is fuel the demand for cord blood banking services.Rise in hematopoietic stem cell transplantation rates is also major factor for boosting the growth of the cord blood banking services market.The transplantation is mostly performed for the treatment of bone marrow or blood cancers.Private Cord Blood Bank Segment to Dominate MarketBased on type, the global cord blood banking services market has been divided into private cord blood bank and public cord blood bank.
More

Top